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ABSTRACT
* 
The aim of the study was to quantify clinical 
pharmacists’ workload in Australia. Specific 
objectives were to perform a direct observation of 
the pattern of clinical activities in two acute hospitals 
and compare that with previously documented self-
reported patterns. We were also interested in 
identifying what records kept by pharmacists would 
capture all the activities they perform. 
Methods: An observer recorded the activities of 
clinical pharmacists on six separate days in the 
medical and surgical wards of two Melbourne 
metropolitan hospitals. We examined resultant data 
to determine suitable records by which clinical 
pharmacists could capture all the activities they 
perform. To compare the observed pattern of 
clinical activities with those earlier self-reported by 
pharmacists, we categorised our data using the 
Pharmacy Activity Codes present in the penultimate 
version of the ICD-10-AM classification system. 
Results: The observer recorded the performance of 
807 workload ‘events’, representing 28 separate 
types of activities. When compressed into the 
Pharmacy Activity Codes formerly used in the ICD-
10-AM classification system, the pattern of activities 
identified by direct observation matched that which 
had previously been self-reported by pharmacists. 
The majority of the activities performed could be 
captured by completion of a Pharmaceutical Care 
Plan and by recording pharmacists’ interventions to 
a database. The remaining activities may be 
recorded for departmental workload purposes in a 
simple template format. 
Conclusion: The pattern of clinical pharmacist 
activity at the two hospitals was confirmed by direct 
observation as similar to that previously reported in 
other Australian hospitals. A Pharmaceutical Care 
Plan, a database for intervention recording and a 
simple workload template provide the means to 
record all activities that clinical pharmacists perform. 
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RESUMEN 
El objetivo del estudio fue cuantificar la carga de 
trabajo de los farmacéuticos clínicos en Australia. 
Los objetivos específicos fueron realizar una 
observación directa del os modelos de actividades 
clínicas en dos hospitales de agudos y compararlas 
con los modelos que habían sido previamente auto-
reportados. También estábamos interesados en 
identificar que registros llevados los farmacéuticos 
podrían capturar todas sus actividades. 
Métodos: Un observador registraba las activiades 
del os farmacéuticos clínicos en seis dias separados 
en los servicios de médicos y quirúrgicos de dos 
hospitales metropolitanos de Melbourne. 
Examinamos los datos resultantes para determinar 
registros adecuados con los que los farmacéuticos 
clínicos podrían registrar todas las actividades que 
realizaban. Para comparar los modelos de 
actividades clínicas con las auto-reportadas 
anteriormente, categorizamos los datos utilizando 
los Códigos de Actividad Farmacéutica (CAF) 
presente sen la penúltima versión del sistema de 
clasificación CDI-10-AM. 
Resultados: El observador registró las actividades 
de 807 eventos de trabajo, que representaron 28 
tipos diferentes de actividades. Al comprimirlos en 
los CAF anteriormente usados en el sistema CDI-
10-AM, los modelos de actividad identificados por 
observación directa se ajustaban al os que habían 
sido previamente auto-comunicados por los 
farmacéuticos. La mayoría del as actividades 
realizadas podía ser capturada en la 
cumplimentación de un plan de atención 
farmacéutica y en registrar las intervenciones del 
farmacéutico en una base de datos. El resto del as 
actividades puede registrarse para análisis de carga 
de trabajo del departamento en un modelo de 
formato simple. 
Conclusión: El modelo de la actividad de un 
farmacéutico clínico se confirmó por observación 
directa como similar a los previamente comunicado 
en otros hospitales australianos. Un plan de 
atención farmacéutica, una base de datos para 
registro de intervenciones y una simple hoja de 
registro de carga de trabajo proporcionan los 
medios de registro de todas las actividades que 
realizan los farmacéuticos clínicos. 
 
Palabras clave: Carga de trabajo. Hospitales. 
Farmacéuticos. Australia. 
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INTRODUCTION 
Pharmacists practicing at ward level perform a 
constellation of tasks – clinical pharmacy services – 
for hospital inpatients in order to promote the safe 
and effective use of medicines. The range of 
services in different practice settings is well 
described.
1-3 Less well documented is the range of 
activities that comprise these services and their 
relationship to individual patient need. 
In Australian reports describing how pharmacists 
document their services, the source of data about 
the activities of clinical pharmacists is usually 
derived from records kept by the pharmacists 
themselves. These data can be recorded by 
pharmacists in the normal course of their work
4 or, 
for specifically determining this information, by use 
of a self-reporting time-log instrument.
5 A few 
reports exist describing the recording by direct 
observation of the activities of clinical pharmacists, 
but these reports are derived from elsewhere.
6,7 To 
our knowledge, there have been no Australian 
reports concerning the use of an observer to record 
clinical pharmacists’ activities.  
Within the Australian practice setting, reports show 
attempts at documentation for the purpose of 
describing the input required by pharmacists to 
provide clinical services. Early reports from Victoria
8 
and Western Australia (WA)
5 describe the activities 
performed by clinical pharmacists and include some 
analyses of the average cost or time involved to 
provide these pharmacy services per occupied bed. 
Recently, more reports of clinical pharmacy 
documentation have appeared at the local and at 
the national level. Two hospitals in WA reported a 
method of recording pharmacists’ activities that 
could be quantified by pharmacist, by ward or by 
medical team.
4 A national survey of clinical 
pharmacy documentation practices showed the 
extent to which pharmacists documented their 
clinical services.
9 The authors noted the lack of 
uniformity between sites in the nature of 
documentation and found that most documentation 
quantified only the number of activities performed 
per ward or per pharmacist. While reporting the 
number of activities performed for each individual 
patient took place about one-third of the time, the 
actual cost (or time) of pharmacy service provision 
per patient could be reported by only 2.5% of sites.
9  
As a first step in our aim to evaluate systematically 
pharmacists’ clinical activities and their contribution 
to patient care, we sought to identify the range of 
clinical activities performed by pharmacists. Our 
objective was to use an observer to confirm patterns 
of clinical pharmacy activities that have been self-
reported by pharmacists themselves in earlier 
studies and to identify what records kept by 
pharmacists of their clinical activities would be 
needed to capture all of the activities they 
performed and so quantify the workload of 
pharmacists as they provide clinical services to 
individual patients. Australian Health Ministers have 
recently mandated a process of pharmaceutical 
review for patients in Australian hospitals.
10 
Quantifying clinical pharmacists’ workload will 
thereby be important in establishing the extra 
resources required to provide this service for all 
patients. 
 
METHODS  
We conducted the study in the general medical and 
surgical wards of two acute general hospitals in 
Melbourne, The Northern Hospital (TNH) and 
Western Hospital Footscray (WHF). No specialist 
wards, such as renal wards, were included. This 
setting was chosen as it would provide a diverse 
range of medical and surgical presentations that 
require many clinical services that pharmacists can 
provide. In common with metropolitan teaching 
hospitals in Australia, TNH and WHF provide clinical 
pharmacy services. These services include the 
review of medication orders, provision of information 
on drugs and medicines to both patients and to 
other clinical staff and the intervention in and 
monitoring of drug therapy through the identification 
of potential or actual medication-related problems.
3 
We identified the actual activities performed by 
pharmacists by using an observer (in a modified 
work sampling technique) to record the activities 
that the pharmacists performed. The observer was 
a pharmacist with experience in providing clinical 
services to hospital inpatients and who had previous 
experience in pharmacy practice research. While 
we originally sought ethics approval for this study, 
neither the Human Research and Ethics 
Committees of Northern Health (TNH) nor of 
Melbourne Health (on behalf of WHF) required 
approval for the study in regard to the patients or 
the pharmacists, as they regarded it as a ‘staff audit 
with minimum patient impact’. 
To aid the observer in recording activities without 
the need for continual handwriting, we compiled a 
list of 27 types of activities and assembled them on 
a customized form – the data collection sheet. The 
activities listed on the sheet were compiled based 
on literature review and the experience of the 
researchers. Observed activities that had not been 
included in the sheet were recorded by way of 
freehand note on the back of the form. The observer 
used a separate form to record the activities 
performed by pharmacists for each patient by 
circling the ‘Y’ symbols to indicate those events 
observed. We did not attempt to quantify all (i.e. 
repeated) activities performed for each patient, nor 
did the observer record the times taken to perform 
activities as we sought only to identify the complete 
range of activities carried out.  
Each type of activity observed (including multiple 
observations of the same activity) was recorded as 
an ‘event’. Observations took place in the medical 
and surgical wards on three non-sequential days on 
each hospital site during March and April, 2004. 
Each day, on each site, the observer accompanied 
a different pharmacist while they undertook their 
clinical duties in their allocated wards. Stuchbery P, Kong DCM, DeSantis GN, Lo SK. Identification by observation of clinical pharmacists’ activities in a 
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Table 1. Summary of the events recorded by observer using the Data Collection Sheet and by separate 
recording by freehand note 
Events Recorded Using Data Collection Sheet 
1. Medication Review     481  59,6% 
        - review medication chart  171       
        - annotate chart  97       
        - review IV therapy chart  12       
        - review observation chart  36       
        - review patient history  75       
        - check allergy/previous drug reaction  31       
        - patient interview  29       
        - family/carer interview  7       
        - dose adjustment  7       
        - dosing interval changed  3       
        - dose form changed  0       
        - drug change required  13       
        - formulary management change  0       
 2. Drug Monitoring          
    - check blood levels/pathology     67  8,3% 
        - aggregate (not further subdivided)
a          
    - check therapy per guidelines
b     68  8,4% 
        - aggregate (not further subdivided)          
    - arrange pathology test     4  0,5% 
        - aggregate (not further subdivided)          
    - change therapy     2  0,2% 
        - aggregate (not further subdivided)          
3. Drug/Product Counselling or Information    66  8,2% 
        - patient  18       
        - medical/nursing staff  48       
        - written CMI supplied
c  0       
        - written drug information supplied  0       
4. Discharge Planning     88  10,9% 
        - check script  21       
        - items required for dispensing  29       
        - counsel patient  11       
        - alteration required  9       
        - check PBS status
d  18       
        - dose administration aid  0       
Events Recorded Not Using Data Collection Sheet 
   Other activities observed          
        - total (not further subdivided)
e     31  3,8% 
   Total 'Events' Observed     807  100,0% 
a) Recorded by therapeutic drug group on data collection sheet - not shown in this analysis. 
b) Considered as medication review activity for subsequent aggregate analyses. 
c) CMI = consumer medicines information 
d) PBS = Pharmaceutical Benefits Scheme; Australia's subsidised medicine scheme for community 
patients and those discharged from hospital 
e) In initial aggregate analysis, 9 events classified as 'medication review', 3 as 'drug information', 7 as 
'discharge planning and 12 as 'other'. 
In ICD-10-AM analysis, 10 classified as 'advocacy/community liaison', 3 as 'provision of drug information' 
and 18 as 'other patient management'. 
 
We analysed the data collected by categorizing 
them according to four major activity groupings 
associated with different stages of inpatient care - 
medication review, monitoring activities, provision of 
counselling or drug information and discharge 
planning. These groupings were devised to aid in 
subsequent presentation of the results and showed 
activities performed by pharmacists at different 
stages of a patient’s stay in hospital. We considered 
that this may aid in our objective to identify suitable 
records made by pharmacists that could quantify 
the activities they performed on behalf of each 
patient. To enable comparison with previously 
published work,
11 we also categorized data 
according to the Pharmacy Activity Codes used in 
the penultimate version of the Australian edition of 
the International Classification of Disease 
classification system (ICD-10-AM).
12 The ICD-10-
AM is an Australian modification of the ICD-10 
coding system developed by WHO. The penultimate 
version of ICD-10-AM, extant at the time of the 
earlier study,
11 included a number of ‘pharmacy 
activity codes’ by which it was possible to record 
clinical activities by pharmacists under the ICD 
system. 
 
RESULTS  
During the study the observer recorded the 
performance by six pharmacists (three on each site) 
of 807 workload ‘events’, representing 28 separate 
types of activities. These took place on behalf of 
195 inpatients; each pharmacist thereby provided a Stuchbery P, Kong DCM, DeSantis GN, Lo SK. Identification by observation of clinical pharmacists’ activities in a 
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clinical service to an average of 33 patients on each 
day of observation. Pharmacists performed an 
average of 4 activities for each patient (range 0-10) 
on the day of observation. Of these 807 workload 
‘events’, 776 (96.2%) were recorded from the list of 
activities provided on the data collection sheet. A 
further 31 events (3.8%) were not accounted for in 
the list. The most frequently performed activities 
were review of the medication chart, annotation of 
the medication chart and review of the patient 
history, these activities comprising 171 (21.2%), 97 
(12%) and 75 (9.3%) respectively of the total events 
observed (Table 1). 
Approximately equal numbers of the 31 events 
recorded by freehand note took place on each site. 
On both sites the majority of these events 
concerned liaison, either between staff or externally 
with carers or primary treatment providers. The 
remainder represented stock management and 
administrative issues. 
Examining activities that represented direct contact 
with the patient or their carer, the data show that 
pharmacists conducted interviews with the patient 
or their carer on 36 occasions - or 18.5% of the 195 
patients whose treatment was reviewed by a 
pharmacist. Other activities that represented direct 
patient contact (provision of drug information, 
medication counselling and liaison about what 
medication was required to be dispensed on 
discharge) occurred on a further 46 occasions 
(23.6%). Some patients (or their carer) received 
direct contact from the pharmacist for more than 
one activity (e.g. medication history interview as 
well as provision of medication counselling). The 
total number of patients or their carers with whom 
the pharmacist made direct contact for one or more 
reasons was 59 (30.2%). At each hospital, the 
pharmacist liaised with the patient or their carer for 
more than one reason (i.e. to seek or provide 
different information) to the same extent - on 43.5% 
of occasions at TNH and on 44.4% at WHF. 
Table 2 shows the reclassification of the observed 
activities according to the Pharmacy Activity Codes 
in the penultimate version the ICD-10-AM disease 
classification system. This reclassification required 
the removal of 34 events that represented the 
pharmacist’s role in initiating a change to treatment. 
These pharmacy ‘interventions’ were not included in 
the ICD-10-AM classification system and this 
amendment reduced the total number of events to 
773. Under this reclassification, the largest 
contributions to observed events came from 
activities associated with medication chart review 
(53.7%) and from clinical review activities (21.6%). 
Each of the remaining seven activity classifications 
represented less than 10% of observed events, with 
the largest of these from the provision of drug 
information (48 events (6.6%)).  
There were no significant differences between the 
frequency of activities performed at TNH and WHF 
(chi-sq=15.1, df=8, p=0.06; detailed data not 
shown). Medication order review was the most 
frequently observed activity at TNH and WHF 
(51.4% vs. 55.4% of activities respectively) with 
clinical review activities respectively contributing 
26.1% and 18.2% of activities conducted. All other 
seven activity classifications contributed less than 
10% of activities observed on each site, with 
provision of drug information being the next highest 
at both TNH (5.2%) and WHF (7.0%). 
Table 2. Comparison of combined observations at the two 
hospitals with an earlier report of the relative frequencies of 
pharmacists’ clinical activities. 
 Combined 
Totals
a 
Previous 
Report
b 
Number of patients  195  NR
c 
Former ICD-10-AM Pharmacy Activity Codes 
Medication history 
interview  36 4.7% 1398 7.6% 
Medication order review  415  53.7%  9772  53.1% 
Clinical review  167  21.6%  3835  20.8% 
Adverse drug reaction 
management  31 4.0%  167 0.9% 
Therapeutic drug 
monitoring  16 2.1%  763 4.1% 
Patient medication 
counselling  29 3.8% 1369 7.4% 
Provision of drug 
information  51 6.6%  778 4.2% 
Advocacy/community 
liaison  10 1.3%  166 0.9% 
Other patient 
management  18 2.3%  154 0.8% 
TOTAL 773    18402   
Interventions 34    NR   
a) Combined totals of observations at The Northern Hospital 
and at Western Hospital Footscray 
b) Dooley MJ, McLennan DN, Galbraith KJ, Burgess NG. 
Multicentre pilot study of a standard approach to 
document clinical pharmacy activity. Aust J Hosp Pharm 
2000; 30: 150-6. 
c) Not recorded 
Table 2 also shows a comparison with pharmacists’ 
clinical activities previously self-reported by 
pharmacists in a national study.11 Medication order 
review represented 53.7% of pharmacists’ workload 
in this study vs. 53.1% in the earlier study 
(p=0.738), with clinical review activities comprising 
a further 21.6% (this study) and 20.8% (p=0.584) in 
the earlier study respectively. All other workload 
activities by ICD-10-AM Pharmacy Activity Codes 
comprised less than 10% of pharmacists’ workload 
in both studies. 
 
DISCUSSION 
We believe this is the first Australian study that has 
used an observer to identify the activities of clinical 
pharmacists. In capturing activities performed, but 
not the time involved, we thereby employed a more 
objective approach and robust sampling technique. 
Work sampling has been previously described for 
work measurement in pharmacy research outside 
Australia.
13,14 In this study, the range of activities 
performed by clinical pharmacists was in 
accordance with that expected. We thereby 
confirmed, by using an observer, the range of 
activities that clinical pharmacists record 
themselves using self-reporting records in the 
Australian setting.
11  
When designing the data collection sheet, we 
included as many activities as we could anticipate 
on this document, so as to facilitate the recording of Stuchbery P, Kong DCM, DeSantis GN, Lo SK. Identification by observation of clinical pharmacists’ activities in a 
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as many activities as possible. In a previous study, 
an observer recorded the activities of clinical 
pharmacists according to a list defined from the 
authors’ experience.
7 All observations fell within the 
list although two categories of ‘other duties’ (e.g. 
answering pagers for non-ward-related requests) 
and ‘unproductive time’ (e.g. time spent socialising 
with other staff) comprised 10% of recorded 
activities and thereby represented a potential 
taxonomy for unanticipated activities. During our 
study, more than 96% of workload ‘events’ were 
recorded by annotating recognized entries on the 
data collection sheet; less than four per cent of the 
observed workload represented activities that had 
not been anticipated. The workload pattern of the 
pharmacists thereby followed a conventional model 
of clinical pharmacy practice.
15 In seeking to identify 
pharmacists’ clinical activities and the records by 
which they could be recorded, this finding provided 
reassurance that our methodology identified the 
pattern of pharmacist’s activities that typifies 
practice in a hospital inpatient setting. 
The majority of workload events (nearly 70%) were 
associated with activities concerning the initial 
review of patients and of the medication ordered for 
them. This was similar to results reported in other 
studies.
7,11,16 The relatively high proportion of 
activities associated with patient discharge is 
consistent with other reports that have described 
pharmacist involvement at the time of discharge 
prescription preparation to promote the optimum 
and efficient supply of discharge medication.
17,18 We 
believe that the recent introduction of the 
Pharmaceutical Benefits Scheme (PBS) for 
discharge prescriptions in some Australian States 
(including Victoria) is responsible for this finding in 
this study. The PBS is a subsidised medicines 
scheme for patients in the community and for those 
being discharged from hospital. The technical 
requirements of prescription writing for the PBS are 
difficult for junior prescribers and extra pharmacist 
input into this point in the discharge process has 
become more common as it facilitates patient 
discharge.
19 
While the majority of workload events performed by 
the pharmacists concerned the review of medication 
ordered for patients in the context of the patients’ 
clinical and social circumstances, pharmacists 
made direct contact with the patient in less than 
one-third of patients. The study was carried out as a 
series of ‘snapshot’ observations on non-
consecutive days and, for patients with whom direct 
contact was not observed, it is possible that patient 
contact occurred on another day during each 
patient’s admission. However, given the consistency 
of this observation on six separate days in the high-
turnover medical and surgical wards of the two 
hospitals, it is possible that patient contact was not 
a principal focus for the pharmacists. If this was the 
case, it represents a missed opportunity for 
pharmacists to add value to the process of 
medication review through their specific knowledge 
of medications and medication-related 
problems.
20,21 
Reclassification of the observed workload activities 
according to the Pharmacy Activity Codes used in 
the ICD-10-AM disease classification system 
provided confirmation that the practice patterns of 
the pharmacists in this study did not differ from 
those observed in a previous national study.
11 This 
previous study sought to confirm that the activities 
of clinical pharmacists could be reported using the 
‘pharmacy intervention codes’ extant in the 
penultimate version of the ICD-10-AM classification 
system.
12 A subsequent revision of this 
classification system collapsed the existing nine 
pharmacy activity codes to a single code, rendering 
the new code structure unsuitable for standardising 
pharmacy activity reporting. We found no significant 
differences in the practice patterns of pharmacists 
at TNH and WHF. In addition, there was close 
similarity (Table 2) between the self-reported activity 
patterns of pharmacists in other Australian States 
and Territories and the patterns recorded by an 
observer in our study; all these provided additional 
assurance that our findings are representative of 
Australian practice and have the potential to be 
applied in other settings. 
Three ICD-10-AM activity codes viz. (i) medication 
history interview, (ii) patient medication counselling 
and (iii) advocacy/community liaison, represent a 
valuable source of information for other current and 
subsequent treatment providers and thereby should 
form part of the patient’s medical record. One way 
in which this may be achieved is through recording 
this information on a Pharmaceutical Care Plan. 
Pharmaceutical Care is a model for pharmacy 
practice defined as ‘the process through which a 
pharmacist co-operates with a patient and other 
professionals in designing, implementing and 
monitoring a therapeutic plan that will produce 
specific therapeutic outcomes’.
22 A Pharmaceutical 
Care Plan is the component of the medical record 
through which this process may be documented.
23 
An advantage of implementing a Pharmaceutical 
Care Plan would be to encourage direct contact 
between pharmacists and patients so as to provide 
more opportunities to add value to the medication 
review process through pharmacists’ detailed 
knowledge of medicines and their capacity to 
identify potential medication-related problems.
24 
The remaining six components of the ICD-10-AM 
Pharmacy Activity Codes are principally records of 
pharmacy workload that need not necessarily form 
part of the medical record. While the conduct of 
these activities may sometimes lead to relevant new 
information about the patient (such as an adverse 
drug reaction or a change to treatment resulting 
from therapeutic drug monitoring), such incidents 
would be separately recorded as an adverse drug 
reaction alert or a pharmacy intervention 
respectively. The conduct of the majority of these 
six activity codes represent checking and review 
activities that signify a clinical pharmacist’s 
workload and do not need to be communicated to 
other health workers. An advantage of using the 
ICD-10-AM Pharmacy Activity Codes for this 
purpose is that they include definitions of what 
these activities represent, thereby encouraging 
standardisation. The lack of standardisation in Stuchbery P, Kong DCM, DeSantis GN, Lo SK. Identification by observation of clinical pharmacists’ activities in a 
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clinical activity documentation has been noted as 
inhibiting practice-based research and identification 
of the pharmacist’s contribution to patient care.
9,15,25 
Records of pharmacy interventions should ideally 
be made in database format, as this aids 
classification and analysis. Many reports 
demonstrate the use of databases to record 
interventions, often in a bespoke form that impedes 
comparison between sites.
26,27 An alternative 
approach would be to utilize a database format that 
has common application in many practice settings, 
such as the Riskman database.
28 This would have 
the advantage of allowing the potential for 
comparing and benchmarking intervention rates and 
patterns between hospitals. 
In recommending that pharmacists utilise a 
document such as a Pharmaceutical Care Plan to 
promote contact with the patient, to assist with 
medication reconciliation and to identify medication-
related problems, we recognize that undertaking 
this activity for as many patients as possible 
represents a significant time commitment. Likewise, 
recording all interventions to treatment takes time. 
While we recognize that this represents a challenge 
to pharmacy management to meet this resource 
requirement, we believe that these activities provide 
the best means of identifying, resolving and 
documenting medication-related problems and the 
pharmacist’s contribution to this task. 
We acknowledged that using an observer may 
induce a ‘Hawthorne effect’, where subjects under 
observation tend to increase their work 
performance.
7,29 Countering this effect, however, 
was our use of an observer who was recognized as 
a peer by the pharmacists involved. Also, there was 
no performance ‘rate’ associated with the 
observations and the pharmacists were just advised 
that the observer was recording ‘the activities that 
you perform’. In this study, we have utilized a single 
observer and did not conduct any inter- and intra-
reliability testing.
30 
During the periods of observation, the observer 
accompanied different pharmacists to different 
wards on different days, as our principal aim was to 
give the observer the opportunity to observe the 
greatest range of activities performed by clinical 
pharmacists as possible. The nature of the testing 
environment was thereby dynamic and the capacity 
to compare results obtained in a stable test setting 
was thereby limited. The ward environment (patient 
mix, the ‘pace’ of activity and other distractions) can 
vary from day to day, further limiting the utility of 
such exercises. We also recognize that 
observations that needed to be made by freehand 
note may have been under reported; our results 
may thereby have biased observations in favour of 
activities that could be readily selected from the 
data collection sheet. 
In summary, we have identified the range of clinical 
activities performed by pharmacists in an Australian 
hospital inpatient setting. The records kept by 
pharmacists that could be used to provide a 
complete picture of clinical pharmacist activities 
should include a Pharmaceutical Care Plan, a 
database for intervention recording and a simple 
workload template. These findings have facilitated 
the commencement of an important study, viz: 
quantifying the relationship between the activities of 
clinical pharmacists and the patient’s diagnosis 
related group (DRG). An improved understanding of 
this relationship is critical in supporting cost-
effective delivery of pharmacy services and 
optimised patient care. 
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